Onxeo Adjusts Direction With Acquisition Of DNA-Repair Interference Platform
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm that was focused on technology to reformulate old drugs gains platform for novel drugs that will induce cell death in orphan oncology indications.